Institutional Investors Accumulate Nemetschek Shares Amid Price Weakness
26.03.2026 - 06:37:46 | boerse-global.de
Despite posting record revenue, raising its dividend, and providing robust future guidance, shares of software specialist Nemetschek have nearly halved in value since their peak last August. As the stock price approaches a 52-week low, a notable trend has emerged: major institutional investors are using the weakness to increase their holdings.
Financial Performance Contrasts with Market Sentiment
The company's operational performance tells a story of strength. For the full year 2025, Nemetschek achieved a milestone, surpassing the billion-euro revenue mark for the first time in its history. Sales climbed by 19.7% to reach €1.191 billion. Profitability also improved, with the EBITDA margin expanding to 31.2%. Looking ahead to 2026, management forecasts further revenue growth of 14-15% and expects the EBITDA margin to land between 32% and 33%.
Shareholders are set to benefit from a consistent dividend policy. The board will propose a dividend of €0.68 per share at the Annual General Meeting on May 21, marking the thirteenth consecutive annual increase and a rise of approximately 24% over the prior year's payout.
Major Funds Report Increased Stakes
Recent regulatory filings reveal significant buying activity by heavyweight investors. Amundi S.A. crossed the 3% reporting threshold on March 10, 2026, and now holds 3.07% of the voting rights, equivalent to 3,547,464 votes. Shortly after, on March 25, a separate notification was filed by BlackRock, triggered by a threshold crossing at the level of one of its subsidiary entities.
Should investors sell immediately? Or is it worth buying Nemetschek?
These strategic accumulations are occurring while the share price trades around €65, a level that stands significantly below its key moving averages. The 200-day moving average, for instance, sits near €98, highlighting the substantial discount at which the stock is currently changing hands.
Analysts Adjust Targets but Maintain Confidence
The recent share price decline appears rooted more in sector-wide sentiment than company-specific fundamentals. The European software sector has faced headwinds. On March 13, Barclays analyst Sven Merkt reduced his price target for Nemetschek from €120 to €95. However, he maintained an "Overweight" rating on the stock, noting that while the sector remains sensitive to AI-related news and many investors are still heavily positioned, valuations are slowly becoming more attractive. This view was echoed by Jefferies, which reaffirmed its "Buy" recommendation on March 16.
Nemetschek is actively addressing market concerns around artificial intelligence with a clear, three-pillar strategy encompassing in-house product development, targeted acquisitions, and strategic partnerships. A key initiative is the agent-based Nemetschek AI Assistant, designed to integrate AI functionality across the entire building lifecycle—a direct move to reassure skeptical investors.
Nemetschek at a turning point? This analysis reveals what investors need to know now.
With convincing financials, ambitious guidance, and a growing dividend, the company's foundation seems solid. The institutional buying could signal an impending stabilization in the share price, a theory that upcoming quarterly results will test. A Relative Strength Index (RSI) reading of 33 suggests the stock is technically in oversold territory, potentially supporting the case for a near-term rebound.
Ad
Nemetschek Stock: New Analysis - 26 March
Fresh Nemetschek information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Kaufen, halten oder verkaufen? So schätzen unsere Börsenprofis Institutional Aktien ein!
Für. Immer. Kostenlos.

